This cohort study found no significant association between the preoperative use of glucagon-like peptide-1 receptor agonists (GLP-1 ...

A product development expert explains how the swift rise of these anti-obesity medications is fueling new food trends.

A prediction tool to help guide GPs choosing treatments for type 2 diabetes could improve blood glucose control and the need ...

Peptide therapeutics, such as GLP-1a (glucagon-like peptide-1 agonists), offer promising treatments for weight control and ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with ...

The study, published in the Journal of the American Medical Association (JAMA), found that SGLT2 inhibitors and GLP-1 ...

For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a modestly lower risk for depression compared with dipeptidyl peptidase-4 ...

Taiwan: A recent cohort study has highlighted the potential benefits of combining glucagon-like peptide-1 receptor agonists ...

If you’ve nodded “yes” to any of these statements, you might be experiencing food noise. What exactly is food noise?Food noise is not an actual medical term but a colloquial one often used to describe ...

A Central Illinois cardiologist breaks down the potential benefits of GLP-1 medications on heart health. It was one of the ...

AbbVie is entering the obesity treatment market with a $2.3bn licensing agreement to acquire global rights to GUB014295, a ...